Treatment
Treatment A clinical trials
We’re tracking 8,322 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07001111Recruiting
Taping therapy for cubital tunnel syndrome pain
This trial tests if a special tape placed on the arm can help reduce pain and improve symptoms in people with cubital tunnel syndrome. It may be a good option if you have arm pain and have not had surgery or certain injections recently.
Istanbul, UskudarAges 18–65 - NCT07000383Recruiting
Gelsectan for diarrhea-predominant IBS
This trial tests if Gelsectan, a dietary supplement, can safely reduce diarrhea and abdominal pain in people with diarrhea-predominant irritable bowel syndrome (IBS-D). It may be a new option for managing your symptoms.
Ho Chi Minh City, District 5Ages 18 years+ - NCT06997549Recruiting
Review of mental health treatment outcomes
This study looks back at information from a large database of people who received mental health treatments. It aims to understand how well treatments worked and what factors influenced outcomes.
Malvern, PennsylvaniaAges 5–100 - NCT06997081RecruitingPhase 2
ERd combination for newly diagnosed multiple myeloma
This trial tests a combination of three drugs (elranatamab, lenalidomide, and dexamethasone) for people newly diagnosed with multiple myeloma. The goal is to see if this treatment can lead to a very deep response (no detectable cancer cells) in the bone marrow.
Miami, FloridaAges 18 years+ - NCT07002112RecruitingPhase 1
A trial of a dual-target CAR-T therapy for blood cancers
This trial tests a new treatment that uses a virus to make your own immune cells attack two targets on cancer cells. It is for people with B-cell blood cancers that have come back or not responded to other treatments.
Hefei, AnhuiAges 18 years+ - NCT05860673Recruiting
Minimally invasive vs standard surgery for adolescent scoliosis
This study compares a less invasive surgical approach with the usual back surgery for adolescent idiopathic scoliosis (a sideways spine curve that starts in the teen years). It aims to see which approach works better and is easier to recover from.
BolognaAges 12–25 - NCT05813418Recruiting
Finding blood and other clues for immune side effects
This study looks for early “predictive clues” (often blood or test markers) that can forecast immune-related side effects in people treated with immune checkpoint medicines. The goal is to help doctors recognize who may be more likely to have these side effects while receiving treatment.
Amiens, PicardieAges 18 years+ - NCT05905172RecruitingPhase 3
Hydronidone for long-term treatment of hepatitis B scarring
This Phase 3 study tests whether hydronidone capsules can help people with long-term hepatitis B–related liver scarring (fibrosis). It aims to track whether treatment reduces or delays serious liver complications over time.
Beijing, Beijing MunicipalityAges 18–65 - NCT06945523RecruitingPhase 1
CAR-T cell therapy for CEA-positive advanced lung cancer
This trial tests a treatment using your own immune cells, modified to target a protein called CEA on lung cancer cells. It's for people with advanced lung cancer that has gotten worse after at least one prior treatment.
Wuhan, HubeiAges 18 years+ - NCT06188195Recruiting
Preventing newborn breathing problems with steroids
This study tests a plan to prevent a severe newborn breathing problem called NARDS. If your baby's risk is very high, you may be offered a steroid treatment that could help their lungs work better at birth.
ChongqingAges Any age - NCT06959342Recruiting
Brain stimulation to reduce cravings in alcohol use disorder
This trial tests if a gentle brain stimulation technique (tDCS) can help people with alcohol use disorder control their cravings and drinking habits. It is an add-on to your regular treatment.
MannheimAges 18–65 - NCT06990061Recruiting
Radiation therapy for BCG-resistant bladder CIS
This trial tests radiotherapy (high-energy X-rays) for a specific type of early-stage bladder cancer (CIS) that hasn't gone away after BCG treatment. It's for people who can't or choose not to have bladder removal surgery.
Anderlecht, Brussels CapitalAges 18 years+ - NCT06984263Recruiting
Male Lichen Sclerosus: Causes, treatments, and quality of life
This study looks at what causes lichen sclerosus in men, how different treatments work, and how the condition affects daily life. If you have lichen sclerosus or are a man without it, you might help researchers learn more.
UmeåAges 18 years+ - NCT06990659Recruiting
Outpatient vs. Inpatient Liver Cancer Treatment Study
This study compares having your liver cancer treatment (TACE or TARE) as an outpatient versus staying in the hospital overnight. It's for people with primary liver cancer whose liver and kidney function are good enough and who can safely go home the same day with support.
AmiensAges 18 years+ - NCT06989112RecruitingPhase 3
First-line treatment for advanced or recurrent endometrial cancer
This trial tests a new combination of drugs for endometrial cancer that has spread or come back. It aims to see if these drugs can shrink tumors and help people live longer. It is for tumors that have a certain protein (HER2) and are mismatch repair proficient (meaning they have a normal DNA repair system).
Tucson, ArizonaAges 18 years+ - NCT06988605Recruiting
Nemolizumab for teens and adults with moderate-to-severe eczema
This study looks at how well nemolizumab works in everyday practice for people with moderate-to-severe atopic dermatitis (eczema). It helps researchers understand the real-world benefits and safety of this treatment.
Birmingham, AlabamaAges 12 years+ - NCT06985368RecruitingPhase 1
Testing SIBP-A18 for advanced solid tumors
This trial tests a new drug, SIBP-A18, for people with advanced solid tumors that have not responded to standard treatments. It may be an option for those with certain cancers that have a protein called CLDN18.2.
Beijing, Beijing MunicipalityAges 18–75 - NCT06987500RecruitingPhase 1/Phase 2
Study of an experimental drug for advanced solid tumors
This trial tests a new drug called XNW29016 for people with advanced cancer that has stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06988618Recruiting
Real-world use of nemolizumab for adults with prurigo nodularis
This study looks at how well nemolizumab works in real-world settings for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. If you are starting this medication as part of your normal care, you may be able to join.
Birmingham, AlabamaAges 18 years+ - NCT06990464RecruitingPhase 1
Testing a new drug for advanced solid tumors
This trial is testing an investigational drug called SIBP-A19 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
Fuzhou, FujianAges 18–75 - NCT06983041Recruiting
Vaginal cooling device for yeast infection treatment
This trial tests a new vaginal cooling device to treat yeast infections. It may help relieve symptoms like itching, burning, or irritation without medication.
Jacksonville, FloridaAges 22–49 - NCT06991062Recruiting
Brain stimulation and smoking: finding personalized treatments
This study tests whether a non-invasive brain stimulation technique (rTMS) can help people who smoke reduce cravings or change smoking behavior. You'll also have your brain activity recorded with a cap (EEG) and do some vaping tasks.
Houston, TexasAges 21–60 - NCT06986148Recruiting
Comparing antibiotics for childhood pneumonia in clinics
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
Atlanta, GeorgiaAges 1 year–5.9 years - NCT06991998Enrolling by invitation
Comparing tooth graft vs. bone graft for gum disease bone defects
This trial tests whether a graft made from your own extracted tooth works as well as a traditional bone graft, both combined with a special enamel protein, to repair bone loss from gum disease.
Budapest, BudapestAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,322 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.